Pharmaceutical

Historic Collaborative Effort: Pharma Giants Rethink the Future of Life Sciences Transacting at MediLedger Face-to-Face Meeting, Hosted by Cencora

CONSHOHOCKEN, PA / ACCESSWIRE / November 2, 2023 / In what promises to be a pivotal moment for the pharmaceutical…

1 year ago

Pressure BioSciences’ Patented BaroFold Technology Platform for High Efficiency Biopharmaceuticals Manufacturing Featured at International Bioprocess Conference by Leading Global Contract Biologics Manufacturer

Scientists at Lonza Biologics and Pressure BioSciences Presented PBIO's Patented BaroFold Platform for Breakthrough Efficiency and Economics Versus Current Manufacturing…

1 year ago

Protagonist Therapeutics Announces Abstracts Selected for Oral and Poster Presentations at the American Society of Hematology 2023 Annual Meeting

Two oral presentations and three poster presentations elucidate new data relevant to rusfertide, a hepcidin mimetic with potential therapeutic value…

1 year ago

The Third Annual Sickle Cell Caregiver Summit: Empowering Caregivers on a Global Scale

The Sickle Cell Consortium Presents the 3rd Annual Sickle Cell Caregivers Summit Nov. 16-19, 2023NEW YORK, NY / ACCESSWIRE /…

1 year ago

Latina-Led Startup Announces Strong Study Results for AI-Assisted Technology for COPD

Using Acoustic Resonance, Samay's Passive Remote Monitoring Platform and Wearable Device Successfully Measures Air Trapping, a Biomarker to Detect ExacerbationsMOUNTAIN…

1 year ago

Bausch Health Announces Third-Quarter 2023 Results

Revenue of $2.24 billion, up 9% on both a Reported and Organic1 basisYear-over-year revenue growth in all segments on both…

1 year ago

Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates

Third quarter 2023 revenues of $1.8 billion; Company expects 2023 revenues of at least $6 billionSpikevax U.S. market share to…

1 year ago

AlzeCure Presents at Redeye Life Science Day on November 23

STOCKHOLM, SE / ACCESSWIRE / November 02, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…

1 year ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 1, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release…

1 year ago